<?xml version='1.0' encoding='utf-8'?>
<document id="30905707"><sentence text="Effect of Rifampicin on the Plasma Concentrations of Bile Acid-O-Sulfates in Monkeys and Human Liver-Transplanted Chimeric Mice With or Without Bile Flow Diversion."><entity charOffset="10-20" id="DDI-PubMed.30905707.s1.e0" text="Rifampicin" /><entity charOffset="53-73" id="DDI-PubMed.30905707.s1.e1" text="Bile Acid-O-Sulfates" /><pair ddi="false" e1="DDI-PubMed.30905707.s1.e0" e2="DDI-PubMed.30905707.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30905707.s1.e0" e2="DDI-PubMed.30905707.s1.e1" /></sentence><sentence text="The present study examined the significance of enterohepatic circulation and the effect of rifampicin [an inhibitor of organic anion-transporting polypeptide 1B (OATP1B)] on the plasma concentrations of bile acid-O-sulfates (glycochenodeoxycholate-O-sulfate, lithocholate-O-sulfate, glycolithocholate-O-sulfate, and taurolithocholate-O-sulfate) in monkeys and human liver-transplanted chimeric mice (PXB mouse)"><entity charOffset="91-101" id="DDI-PubMed.30905707.s2.e0" text="rifampicin" /><entity charOffset="203-223" id="DDI-PubMed.30905707.s2.e1" text="bile acid-O-sulfates" /><entity charOffset="225-257" id="DDI-PubMed.30905707.s2.e2" text="glycochenodeoxycholate-O-sulfate" /><entity charOffset="259-281" id="DDI-PubMed.30905707.s2.e3" text="lithocholate-O-sulfate" /><entity charOffset="283-310" id="DDI-PubMed.30905707.s2.e4" text="glycolithocholate-O-sulfate" /><entity charOffset="316-343" id="DDI-PubMed.30905707.s2.e5" text="taurolithocholate-O-sulfate" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e3" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e4" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e0" e2="DDI-PubMed.30905707.s2.e5" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e1" e2="DDI-PubMed.30905707.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e1" e2="DDI-PubMed.30905707.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e1" e2="DDI-PubMed.30905707.s2.e3" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e1" e2="DDI-PubMed.30905707.s2.e4" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e1" e2="DDI-PubMed.30905707.s2.e5" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e2" e2="DDI-PubMed.30905707.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e2" e2="DDI-PubMed.30905707.s2.e3" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e2" e2="DDI-PubMed.30905707.s2.e4" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e2" e2="DDI-PubMed.30905707.s2.e5" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e3" e2="DDI-PubMed.30905707.s2.e3" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e3" e2="DDI-PubMed.30905707.s2.e4" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e3" e2="DDI-PubMed.30905707.s2.e5" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e4" e2="DDI-PubMed.30905707.s2.e4" /><pair ddi="false" e1="DDI-PubMed.30905707.s2.e4" e2="DDI-PubMed.30905707.s2.e5" /></sentence><sentence text=" Rifampicin significantly increased the area under the curve of bile acid-O-sulfates in monkeys (13-69 times) and PXB mice (13-25 times) without bile flow diversion"><entity charOffset="1-11" id="DDI-PubMed.30905707.s3.e0" text="Rifampicin" /></sentence><sentence text=" Bile flow diversion reduced the concentration of plasma bile acid-O-sulfates under control conditions in monkeys and the concentration of plasma glycochenodeoxycholate-O-sulfate in PXB mice"><entity charOffset="146-178" id="DDI-PubMed.30905707.s4.e0" text="glycochenodeoxycholate-O-sulfate" /></sentence><sentence text=" It also diminished diurnal variation of plasma lithocholate-O-sulfate, glycolithocholate-O-sulfate, and taurolithocholate-O-sulfate in PXB mice under control conditions"><entity charOffset="48-70" id="DDI-PubMed.30905707.s5.e0" text="lithocholate-O-sulfate" /><entity charOffset="72-99" id="DDI-PubMed.30905707.s5.e1" text="glycolithocholate-O-sulfate" /><entity charOffset="105-132" id="DDI-PubMed.30905707.s5.e2" text="taurolithocholate-O-sulfate" /><pair ddi="false" e1="DDI-PubMed.30905707.s5.e0" e2="DDI-PubMed.30905707.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30905707.s5.e0" e2="DDI-PubMed.30905707.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30905707.s5.e0" e2="DDI-PubMed.30905707.s5.e2" /><pair ddi="false" e1="DDI-PubMed.30905707.s5.e1" e2="DDI-PubMed.30905707.s5.e1" /><pair ddi="false" e1="DDI-PubMed.30905707.s5.e1" e2="DDI-PubMed.30905707.s5.e2" /></sentence><sentence text=" Bile flow diversion did not affect the plasma concentration of bile acid-O-sulfates in monkeys and PXB mice treated with rifampicin"><entity charOffset="64-84" id="DDI-PubMed.30905707.s6.e0" text="bile acid-O-sulfates" /><entity charOffset="122-132" id="DDI-PubMed.30905707.s6.e1" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.30905707.s6.e0" e2="DDI-PubMed.30905707.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30905707.s6.e0" e2="DDI-PubMed.30905707.s6.e1" /></sentence><sentence text=" Plasma coproporphyrin I and III levels were constant in monkeys throughout the study, even with bile flow diversion"><entity charOffset="8-24" id="DDI-PubMed.30905707.s7.e0" text="coproporphyrin I" /></sentence><sentence text=" This study demonstrated that bile acid-O-sulfates are endogenous OATP1B biomarkers in monkeys and PXB mice"><entity charOffset="30-50" id="DDI-PubMed.30905707.s8.e0" text="bile acid-O-sulfates" /></sentence><sentence text=" Enterohepatic circulation can affect the baseline levels of plasma bile acid-O-sulfates and modify the effect of OATP1B inhibition" /><sentence text="" /></document>